Stem cell aggregate suspension compositions and methods of...

Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S383000, C435S384000, C435S366000, C435S375000

Reexamination Certificate

active

08008075

ABSTRACT:
The present invention relates to methods for production of undifferentiated or differentiated embryonic stem cell aggregate suspension cultures from undifferentiated or differentiated embryonic stem cell single cell suspensions and methods of differentiation thereof.

REFERENCES:
patent: 7445931 (2008-11-01), Condie et al.
patent: 7510876 (2009-03-01), D'Amour et al.
patent: 7534608 (2009-05-01), Martinson et al.
patent: 7541185 (2009-06-01), D'Amour et al.
patent: 7625753 (2009-12-01), Kelly et al.
patent: 7695963 (2010-04-01), Agulnick et al.
patent: 7695965 (2010-04-01), Martinson et al.
patent: 7704738 (2010-04-01), D'Amour
patent: 7737253 (2010-06-01), Robins et al.
patent: 2002/0081724 (2002-06-01), Carpenter et al.
patent: 2002/0151054 (2002-10-01), Rathjen et al.
patent: 2003/0113901 (2003-06-01), Hirst et al.
patent: 2003/0203008 (2003-10-01), Gunasekaran
patent: 2005/0233446 (2005-10-01), Parsons et al.
patent: 2005/0266554 (2005-12-01), D'Amour et al.
patent: 2006/0194321 (2006-08-01), Colman et al.
patent: 2007/0015210 (2007-01-01), Ezekiel
patent: 2007/0122905 (2007-05-01), D'Amour et al.
patent: 2007/0154984 (2007-07-01), D'Amour et al.
patent: 2007/0259421 (2007-11-01), D'Amour et al.
patent: 2008/0102063 (2008-05-01), Moviglia
patent: 2008/0113433 (2008-05-01), Robins et al.
patent: 2008/0206343 (2008-08-01), Edinger et al.
patent: 2008/0268534 (2008-10-01), Robins et al.
patent: 2009/0011502 (2009-01-01), D'Amour et al.
patent: 2009/0042287 (2009-02-01), D'Amour et al.
patent: 2009/0093372 (2009-04-01), Agulnick et al.
patent: 2009/0104696 (2009-04-01), Robins et al.
patent: 2009/0220959 (2009-09-01), D'Amour et al.
patent: 2009/0253202 (2009-10-01), D'Amour et al.
patent: 2009/0263896 (2009-10-01), Kelly et al.
patent: 2009/0298178 (2009-12-01), D'Amour et al.
patent: 2009/0311703 (2009-12-01), D'Amour et al.
patent: 2010/0041150 (2010-02-01), Kelly et al.
patent: 2010/0124564 (2010-05-01), Martinson et al.
patent: 2010/0260728 (2010-10-01), Martinson et al.
patent: WO-9953021 (1999-01-01), None
patent: WO-0238741 (2002-05-01), None
patent: 03/014313 (2003-02-01), None
patent: WO-2004029203 (2004-04-01), None
patent: WO-2004076624 (2004-10-01), None
patent: WO-2004090096 (2004-10-01), None
patent: WO-2004090110 (2004-10-01), None
patent: WO-2005063971 (2005-07-01), None
patent: WO-2005116073 (2005-12-01), None
patent: WO-2006016999 (2006-02-01), None
patent: WO-2006017134 (2006-02-01), None
patent: WO-2006020919 (2006-02-01), None
patent: WO-2007002210 (2007-01-01), None
patent: WO-2007051038 (2007-05-01), None
patent: WO-2007103282 (2007-09-01), None
patent: WO-2008013664 (2008-01-01), None
Lim et al. Proteomics, 2:1187-1203, 2002.
Prowse et al. Proteomics, 5:978-989, 2005.
Watanabe, Nature Biotechnology, 25:681-686.
Oh et al. Clin. And Exp. Pharmacology and Physiology, 33:489-495, 2006.
Ludwig et al. Nat. Biotech., 24(2): 185-187, 2006.
Xu et al. Nature Biotech.,19: 971-974, 2001.
Gerami-Naini, 2004, Endocrinology, 145:1517-1524.
Amit et al. Biol. Of Reprod., 70:837-845, 2004.
Thomson PNAS, 92: 7844-7848, Aug. 1995.
Schuldiner et al, 2000, PNAS, 97:11307-11312.
D'Amour et al, 2006, Nature Biotechnology, 26:1392-1401.
Valdimarsdottir et al., Functions of the TGF—superfamily in human embryonic stem cells. APMIS, 113(11-12):773-89, 2005.
NIH (Stem Cells: Scientific Progress and Future Research Directions, Department of Health and Human Services, Chapter 1, pp. 1-4, Jun. 2001.
PCT International Search Report dated Jan. 9, 2009 for PCT/US08/082356 (2 pages).
D'Amour et al., “Efficient differentiation of human embryonic stem cells to definitive endoderm”Nature Biotechnology. 23:1534-41, 2005.
Wang, “Self-Renewal of Human Embryonic Stem Cells Requires Insulin-Like Growth Factor-1 Receptor and ERBB2 Receptor Signaling”Blood110:4111-4119, 2007.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Stem cell aggregate suspension compositions and methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stem cell aggregate suspension compositions and methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stem cell aggregate suspension compositions and methods of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2726604

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.